Cost savings at the end of life

J. J. Mahoney; P. A. Singer; F. H. Lowy; M. Hilberman; A. Mitchell; C. E. Stroud; W. D. Carroll; E. J. Emanuel; L. L. Emanuel

doi:10.1056/NEJM199408183310713

Cost savings at the end of life

J. J. Mahoney, P. A. Singer, F. H. Lowy, M. Hilberman, A. Mitchell, C. E. Stroud, W. D. Carroll, E. J. Emanuel, L. L. Emanuel

Medicine, General Medicine Division

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: In their analysis of proposals to control costs at the end of life, such as the use of advance directives and hospice care, Emanuel and Emanuel (Feb. 24 issue)¹ somehow conclude that an annual saving of $29.7 billion is less than substantial. In most people's view, $30 billion in savings is anything but unsubstantial. For example, $30 billion is enough to provide health insurance to uninsured Americans as part of a plan of universal coverage. These savings can also be critical for people already in the system. On the basis of the Emanuels' estimate, the total savings.

Original language	English (US)
Pages (from-to)	477-479
Number of pages	3
Journal	New England Journal of Medicine
Volume	331
Issue number	7
DOIs	https://doi.org/10.1056/NEJM199408183310713
State	Published - Aug 18 1994

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM199408183310713

Cite this

@article{78017ab359ea424bb8a05702a2d46a2d,

title = "Cost savings at the end of life",

abstract = "To the Editor: In their analysis of proposals to control costs at the end of life, such as the use of advance directives and hospice care, Emanuel and Emanuel (Feb. 24 issue)1 somehow conclude that an annual saving of $29.7 billion is less than substantial. In most people's view, $30 billion in savings is anything but unsubstantial. For example, $30 billion is enough to provide health insurance to uninsured Americans as part of a plan of universal coverage. These savings can also be critical for people already in the system. On the basis of the Emanuels' estimate, the total savings.",

author = "Mahoney, {J. J.} and Singer, {P. A.} and Lowy, {F. H.} and M. Hilberman and A. Mitchell and Stroud, {C. E.} and Carroll, {W. D.} and Emanuel, {E. J.} and Emanuel, {L. L.}",

year = "1994",

month = aug,

day = "18",

doi = "10.1056/NEJM199408183310713",

language = "English (US)",

volume = "331",

pages = "477--479",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Cost savings at the end of life

AU - Mahoney, J. J.

AU - Singer, P. A.

AU - Lowy, F. H.

AU - Hilberman, M.

AU - Mitchell, A.

AU - Stroud, C. E.

AU - Carroll, W. D.

AU - Emanuel, E. J.

AU - Emanuel, L. L.

PY - 1994/8/18

Y1 - 1994/8/18

N2 - To the Editor: In their analysis of proposals to control costs at the end of life, such as the use of advance directives and hospice care, Emanuel and Emanuel (Feb. 24 issue)1 somehow conclude that an annual saving of $29.7 billion is less than substantial. In most people's view, $30 billion in savings is anything but unsubstantial. For example, $30 billion is enough to provide health insurance to uninsured Americans as part of a plan of universal coverage. These savings can also be critical for people already in the system. On the basis of the Emanuels' estimate, the total savings.

AB - To the Editor: In their analysis of proposals to control costs at the end of life, such as the use of advance directives and hospice care, Emanuel and Emanuel (Feb. 24 issue)1 somehow conclude that an annual saving of $29.7 billion is less than substantial. In most people's view, $30 billion in savings is anything but unsubstantial. For example, $30 billion is enough to provide health insurance to uninsured Americans as part of a plan of universal coverage. These savings can also be critical for people already in the system. On the basis of the Emanuels' estimate, the total savings.

UR - http://www.scopus.com/inward/record.url?scp=1642459313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642459313&partnerID=8YFLogxK

U2 - 10.1056/NEJM199408183310713

DO - 10.1056/NEJM199408183310713

M3 - Letter

C2 - 8035850

AN - SCOPUS:1642459313

SN - 0028-4793

VL - 331

SP - 477

EP - 479

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Cost savings at the end of life

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this